Tarsus Pharmaceuticals
TARS
TARS
116 hedge funds and large institutions have $692M invested in Tarsus Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
11.77% more ownership
Funds ownership: 91.33% → 103.11% (+12%)
10% more funds holding
Funds holding: 105 → 116 (+11)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
116
Holding in Top 10
5
Calls
$2.99M
Puts
$458K
Top Buyers
| 1 | +$77.8M | |
| 2 | +$20.8M | |
| 3 | +$6.19M | |
| 4 |
RI
RTW Investments
New York
|
+$5.5M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.86M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$12.3M | |
| 3 | -$9.68M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$8.1M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.44M |